Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine

NCT04690335 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

RSV Infection

Interventions

BIOLOGICAL: MV-012-968
OTHER: Placebo

Sponsor

Meissa Vaccines, Inc.

Collaborators

[object Object]